Coagulopathy and Brain Injury Pathogenesis in Post-Covid-19 Syndrome
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
The post-COVID neurological syndrome has been coined, which describes the functional and structural sequelae of coronavirus infection disease-19 (COVID-19) in the brain. Mild/severe manifestations of the post-COVID neurological syndrome have been identified in approximately 33.00% of COVID-19 survivors. The presence of neurological complications after COVID allowed neuropathologists to investigate in-depth the role of viral infection in neurons. The pathophysiology of the post-COVID neurological syndrome involved the development of a systematic response, including coagulopathy characterized by the formation of microthrombi. Coagulopathy, an old term for a new disease, describes the discrepancy between pro-coagulant and anticoagulant systems due to overexpression of pro-coagulant substances and or their receptors in addition to suppression of the anticoagulant molecules and or their receptors. Vascular endothelial cells and hepatocytes play a central role in the regulation of hemostasis that is disrupted during the acute phase response (APR) of coronavirus-19 (COVID-19). Currently, coagulopathy and inflammation are termed together since both form a complementary system, indicated by the elevation of inflammatory biomarkers (APR) and fibrinolysis biomarkers (D-dimer/fibrin). The later events of the post-COVID neurological syndrome are primarily induced by coagulopathy and direct viral tropism. Therefore, the paper introduces the hypothesis of coagulopathy induced post-COVID neurological syndrome.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
Cardiovascular & hematological agents in medicinal chemistry - 20(2022), 3 vom: 05., Seite 178-188 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Marzoog, Basheer Abdullah [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anticoagulants |
---|
Anmerkungen: |
Date Completed 23.09.2022 Date Revised 07.12.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/1871525720666220405124021 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM339125160 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM339125160 | ||
003 | DE-627 | ||
005 | 20231226002215.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/1871525720666220405124021 |2 doi | |
028 | 5 | 2 | |a pubmed24n1130.xml |
035 | |a (DE-627)NLM339125160 | ||
035 | |a (NLM)35382728 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Marzoog, Basheer Abdullah |e verfasserin |4 aut | |
245 | 1 | 0 | |a Coagulopathy and Brain Injury Pathogenesis in Post-Covid-19 Syndrome |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.09.2022 | ||
500 | |a Date Revised 07.12.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a The post-COVID neurological syndrome has been coined, which describes the functional and structural sequelae of coronavirus infection disease-19 (COVID-19) in the brain. Mild/severe manifestations of the post-COVID neurological syndrome have been identified in approximately 33.00% of COVID-19 survivors. The presence of neurological complications after COVID allowed neuropathologists to investigate in-depth the role of viral infection in neurons. The pathophysiology of the post-COVID neurological syndrome involved the development of a systematic response, including coagulopathy characterized by the formation of microthrombi. Coagulopathy, an old term for a new disease, describes the discrepancy between pro-coagulant and anticoagulant systems due to overexpression of pro-coagulant substances and or their receptors in addition to suppression of the anticoagulant molecules and or their receptors. Vascular endothelial cells and hepatocytes play a central role in the regulation of hemostasis that is disrupted during the acute phase response (APR) of coronavirus-19 (COVID-19). Currently, coagulopathy and inflammation are termed together since both form a complementary system, indicated by the elevation of inflammatory biomarkers (APR) and fibrinolysis biomarkers (D-dimer/fibrin). The later events of the post-COVID neurological syndrome are primarily induced by coagulopathy and direct viral tropism. Therefore, the paper introduces the hypothesis of coagulopathy induced post-COVID neurological syndrome | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 & SARS-CoV2 | |
650 | 4 | |a Homeostasis & hemostasis | |
650 | 4 | |a coagulopathy | |
650 | 4 | |a endothelial dysfunction | |
650 | 4 | |a neurology | |
650 | 4 | |a pathogenesis & pathophysiology | |
650 | 4 | |a post-COVID syndrome | |
650 | 7 | |a Anticoagulants |2 NLM | |
650 | 7 | |a Biomarkers |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Cardiovascular & hematological agents in medicinal chemistry |d 2006 |g 20(2022), 3 vom: 05., Seite 178-188 |w (DE-627)NLM161201482 |x 1875-6182 |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2022 |g number:3 |g day:05 |g pages:178-188 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/1871525720666220405124021 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 20 |j 2022 |e 3 |b 05 |h 178-188 |